118 related articles for article (PubMed ID: 3784919)
1. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes.
Zichella L; Falaschi P; Fioretti P; Melis GB; Cagnacci A; Gambacciani M; Mancini S
Maturitas; 1986 Oct; 8(3):229-37. PubMed ID: 3784919
[TBL] [Abstract][Full Text] [Related]
2. Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
David A; Don R; Tajchner G; Weissglas L
Am J Obstet Gynecol; 1988 May; 158(5):1107-15. PubMed ID: 2967034
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
[TBL] [Abstract][Full Text] [Related]
4. The safety of veralipride.
De Leo V; Morgante G; Musacchio MC; Faldini E; Delia A; Petraglia F
Expert Opin Drug Saf; 2006 Sep; 5(5):695-701. PubMed ID: 16907659
[TBL] [Abstract][Full Text] [Related]
5. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
Carretti N; Florio P; Reis FM; Comai S; Bertazzo A; Petraglia F
Climacteric; 2010 Apr; 13(2):141-6. PubMed ID: 20082603
[TBL] [Abstract][Full Text] [Related]
6. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
[TBL] [Abstract][Full Text] [Related]
7. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
Tortonese DJ
Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
[TBL] [Abstract][Full Text] [Related]
8. [The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride].
Wesel S; Bosuma WB
Sem Hop; 1983 Mar; 59(9):596-9. PubMed ID: 6304907
[TBL] [Abstract][Full Text] [Related]
9. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
Verbeke K; Dhont M; Vandekerckhove D
Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
[TBL] [Abstract][Full Text] [Related]
10. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
Wesel S; Bourguignon RP; Bosuma WB
Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
[TBL] [Abstract][Full Text] [Related]
11. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
Boulot P; Viala JL
Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
[TBL] [Abstract][Full Text] [Related]
12. Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment.
Vercellini P; Vendola N; Colombo A; Passadore C; Trespidi L; Crosignani PG
Gynecol Obstet Invest; 1992; 34(2):102-4. PubMed ID: 1398260
[TBL] [Abstract][Full Text] [Related]
13. Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.
Montemurro D; Rossi GP
J Endocrinol Invest; 2006; 29(7):650-2. PubMed ID: 16957415
[TBL] [Abstract][Full Text] [Related]
14. Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs.
Seeman MV
Gynecol Endocrinol; 2015 Oct; 31(10):751-4. PubMed ID: 26291819
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
Delanian L
Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
[TBL] [Abstract][Full Text] [Related]
16. Endocrinological basis of hot flushes.
Bider D; Mashiach S; Serr DM; Ben-Rafael Z
Obstet Gynecol Surv; 1989 Jul; 44(7):495-9. PubMed ID: 2662075
[TBL] [Abstract][Full Text] [Related]
17. [Veralipride in the treatment of hot flushes in the menopause].
Pasetto N; Piccione E; Baschieri L
Rev Fr Gynecol Obstet; 1985 Feb; 80(3):163-5. PubMed ID: 3922035
[TBL] [Abstract][Full Text] [Related]
18. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
Melis GB; Cagnacci A; Gambacciani M; Paoletti AM; Moggi L; Fioretti P
J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
[TBL] [Abstract][Full Text] [Related]
19. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride versus bromocriptine in infantile autism: a controlled crossover comparative study of two drugs with opposite effects on dopaminergic function.
Dollfus S; Petit M; Menard JF; Lesieur P
J Autism Dev Disord; 1992 Mar; 22(1):47-60. PubMed ID: 1350581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
